Pinned Tweet
Congratulations Professor Eleni Aklillu – winner of the Donald Mackay Medal news.ki.se/congratulations-p…
Eleni Aklillu retweeted
👁️🗨️ Discover ten of the many #EDCTP-supported researchers and leaders whose work is advancing infectious disease research, strengthening scientific institutions and improving public health across sub-Saharan Africa.
🔗 Meet them: global-health-edctp3.europa.…
Eleni Aklillu retweeted
2/2
The four-year project, officially launched on 20 October 2025, includes joint engagements with @SwedeninRW, held at Sida Headquarters, Karolinska Institutet, and Testa Center in Uppsala, reinforcing collaboration in health innovation and manufacturing.
Eleni Aklillu retweeted
UR STRENGTHENS GLOBAL PARTNERSHIPS IN SWEDEN
1/2
A University of Rwanda delegation led by Deputy Vice Chancellor for Finance, Françoise Kayitare Tengera, is in Sweden for the annual project management meeting of the Team Europe Initiative on Manufacturing and Access to Vaccines, Medicines, and Health Technologies in Africa (TEI-MAV+).
Eleni Aklillu retweeted
Strengthening Rwanda’s Clinical Trial Capacity!
From May 7–9, @Uni_Rwanda hosted a high-level stakeholders’ meeting to launch clinical trial capacity building under the #MAVPlus project — a major leap toward Rwanda’s goal of becoming a regional hub for ethical, GCP-compliant trials.
Key outcome: A joint roadmap to guide implementation in partnership with @RBCRwanda, @RwandaHealth, @rwandafda, @IVIGlobalHealth, @expertisefrance, @ki_se, @Sida, CDT-Africa, AHRI & more.
#ClinicalTrials #GlobalHealth #VaccineDevelopment #UniversityOfRwanda #PublicHealthAfrica #CapacityBuilding
Eleni Aklillu retweeted
While opening the training workshop on clinical trials for drugs/vaccines, Vice Chancellor @mdkayihura emphasize that this initiative is a significant step toward building a critical mass of trained scientists and healthcare professionals essential for Rwanda’s key interventions. This includes, among other areas such as clinical research to assess the efficacy and safety of various drugs and vaccines.
Eleni Aklillu retweeted
Today marks the start of a two-week training workshop on clinical trials for drugs/ vaccines, aimed at strengthening the education and training of 22 healthcare professionals and scientists, particularly in clinical trials and biomedical research.
The training brings together participants from key health stakeholders, including UR, @RwandaFDA, @RBCRwanda and referral hospitals. It is facilitated by professors from @karolinskainst and funded by @sanofi and @IVIHeadquarters.
This initiative aligns with #Rwanda’s efforts to advance innovation, #biotechnology, and #biomanufacturing, reinforcing its aspiration to become a leading hub for healthcare innovation in #Africa.
Eleni Aklillu retweeted
Celebrating yet another Milestone!
The PROFORMA project proudly celebrates the achievement of its sixth and final PhD. student, Dr Christabel Khaemba @cnkhaemba, who successfully defended her PhD thesis on 18 December 2024 at Karolinska Institutet.
Eleni Aklillu retweeted
Replying to @EDCTP
@EDCTP funded @ProformaProject proudly announce that its 3rd PhD student, Tigist Dires Gebreyesus from #EthiopianFDA successfully defended her PhD thesis and graduated from the Department of Global Public Health @karolinskainst
@EDCTP3 #EthiopiaFDA @cdtafrica @eleakl
Eleni Aklillu retweeted
@ProformaProject is proud to be part of the ongoing Eleventh #EDCTPForum.Three of our PhD Students have poster presentations
@EDCTP @karolinskainst @ppbkenya @uonbi @tmda_tanzania @muhimbiliuniver @AddisAbabaUni @cdtafrica @eleakl @cnkhaemba @AdamMitangu #EthiopiaFDA – at Paris, France
Eleni Aklillu retweeted
For the in person attendees please visit poster stands #PA074, #PA096 and #PA118 to learn more about the work PROFORMA consortium has been doing in East Africa on #NeglectedTropicalDiseases – at Paris, France
Eleni Aklillu retweeted
Special thanks to @EDCTP for sponsoring two of our PhD students to attend the #EDCTPForum
Eleni Aklillu retweeted
Another milestone for PROFORMA Consortium
Read our latest publication. @karolinskainst @EDCTP
@cnkhaemba @eleakl @ppbkenya
@UMCGlobalSafety @OmondiWyckliff
#SafetySuverillance #MassDrugAdministration
link.springer.com/article/10…
Eleni Aklillu retweeted
The hybrid Risk Management and Communication training #16th,#17th & #25th-#27th for the PROFORMA participating countries was a success.Over 30 participants attended. #pharmacovigilance #riskmanagement #riskcommunication
@EDCTP @Lareb @ppbkenya @RwandaFDA @tmda_tanzania – at Ethiopia
Eleni Aklillu retweeted
The virtual Risk Management and Communication training for the PROFORMA participating countries kick-off was a success today.
@Lareb_NL @EDCTP @ppbkenya @RwandaFDA @tmda_tanzania
#pharmacovigilance
#riskmanagement
#riskcommunication
Eleni Aklillu retweeted
"The real challenge was to reach people. Not a lack of vaccines. People were afraid of absurds "facts". Therefore trustbuilding and outreach is important" - @MArnlov from @RodaKorset
Eleni Aklillu retweeted
.@NordstrmAnders has a top 5 list for a better handling of future pandemics:
1. Effective alarm system that people understand.
2. A different platform for vaccines and treatments. For an effect flow of access around the world.
#almedalen #sverigeivarlden #covid19
Eleni Aklillu retweeted
”Global partnership and research collaborations are essential in global health emergencies to rapidly develop and deploy safe and effective diagnostics, therapeutics, and vaccines and ensure equitable global access to all”, says Professor @eleakl #almedalen2022
Eleni Aklillu retweeted
“It takes both political will and local capacity to respond to the pandemic” says @eleakl of @karolinskainst in @Sida seminar #almedalen as she explains capacity development collaboration
Eleni Aklillu retweeted
The COVID-19 pandemic presented an unprecedented challenge to health systems worldwide, but how do we stop pandemics to begin with? Watch our panel discussion w/ @SidaCarin @thomsen_sarah @NordstrmAnders @Anders_RedCross @eleakl at #Almedalen Mon 4 July! sida.se/seminarier-och-kurse…









































